✦ LIBER ✦
Abciximab reduces urgent target vessel revascularization at 30 days after primary angioplasty, independently of acute angiographic results. The RAPPORT trial
✍ Scribed by S.J. Brener; L.A. Barr; E.D. Cohen; H.J. White; D.J. Moliterno; H.B. Cheek; M.B. Effron; E.J. Topol
- Book ID
- 118589603
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 107 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1558-3597
No coin nor oath required. For personal study only.